Natural killer and lymphokine-activated killer activity in HLA-B8,DR3-Positive subjects
- 1 November 1993
- journal article
- Published by Elsevier in Human Immunology
- Vol. 38 (3) , 226-230
- https://doi.org/10.1016/0198-8859(93)90546-d
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Synergistic effects of interleukin 4 and interleukin 12 on NK cell proliferationCytokine, 1993
- Ancestral haplotypes: conserved population MHC haplotypesHuman Immunology, 1992
- Hla-Bb, Dr3 T Cell Impairhent is Completely Restored by in Vitho Treatment with Interleukin-2Immunopharmacology and Immunotoxicology, 1991
- Central MHC genes, IgA deficiency and autoimmune diseaseImmunology Today, 1990
- Markers of T Lymphocyte Activation in HLA-B8, DR3 Positive IndividualsImmunobiology, 1990
- The Effects of Variations in Human Immune-Response GenesNew England Journal of Medicine, 1989
- Immune functions in healthy blood donors with HLA-DW2 and -DW3 antigensImmunobiology, 1986
- Elevated natural killer cytotoxicity in HLA-B8 and HLA-DR3-positive individualsImmunology Letters, 1986
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Continuous growth and differentiation of human myeloid leukaemic cells in suspension cultureNature, 1977